DENTSPLY SIRONA Inc. (NASDAQ:XRAY)‘s stock had its “buy” rating reaffirmed by equities researchers at Stifel Nicolaus in a report issued on Thursday. They presently have a $66.00 price target on the medical instruments supplier’s stock, down from their previous price target of $70.00. Stifel Nicolaus’ price objective would suggest a potential upside of 18.92% from the stock’s previous close.

Several other research firms have also issued reports on XRAY. BidaskClub lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Wednesday, July 19th. Credit Suisse Group reissued an “outperform” rating and issued a $75.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research report on Thursday, July 13th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a research report on Thursday, July 13th. HC Wainwright began coverage on shares of DENTSPLY SIRONA in a research report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. Finally, Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and nine have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $67.58.

Shares of DENTSPLY SIRONA (NASDAQ XRAY) traded down 1.30% on Thursday, hitting $55.50. 3,519,280 shares of the company’s stock were exchanged. The firm has a market cap of $12.72 billion, a P/E ratio of 35.71 and a beta of 1.26. The stock’s 50 day moving average is $63.39 and its 200 day moving average is $62.35. DENTSPLY SIRONA has a 12 month low of $55.00 and a 12 month high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.65. DENTSPLY SIRONA had a net margin of 9.42% and a return on equity of 7.37%. The company had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. During the same quarter in the previous year, the firm posted $0.76 earnings per share. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. On average, equities analysts predict that DENTSPLY SIRONA will post $2.78 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This piece was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-nasdaqxray-receives-buy-rating-from-stifel-nicolaus/1469149.html.

Large investors have recently bought and sold shares of the stock. BlackRock Inc. raised its stake in DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after buying an additional 13,457,730 shares in the last quarter. Principal Financial Group Inc. raised its stake in DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock worth $330,488,000 after buying an additional 4,950,337 shares in the last quarter. Clearbridge Investments LLC raised its stake in DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock worth $328,313,000 after buying an additional 1,353,040 shares in the last quarter. Point72 Asset Management L.P. purchased a new stake in DENTSPLY SIRONA during the first quarter worth approximately $64,184,000. Finally, Renaissance Technologies LLC raised its stake in DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock worth $65,222,000 after buying an additional 742,700 shares in the last quarter. Institutional investors own 95.17% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.